443 related articles for article (PubMed ID: 19835659)
1. Aberrant extracellular signal-regulated kinase (ERK)1/2 signalling in suicide brain: role of ERK kinase 1 (MEK1).
Dwivedi Y; Rizavi HS; Zhang H; Roberts RC; Conley RR; Pandey GN
Int J Neuropsychopharmacol; 2009 Nov; 12(10):1337-54. PubMed ID: 19835659
[TBL] [Abstract][Full Text] [Related]
2. ERK1/2 can feedback-regulate cellular MEK1/2 levels.
Hong SK; Wu PK; Karkhanis M; Park JI
Cell Signal; 2015 Oct; 27(10):1939-48. PubMed ID: 26163823
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic tyrosine kinase NPM/ALK induces activation of the MEK/ERK signaling pathway independently of c-Raf.
Marzec M; Kasprzycka M; Liu X; Raghunath PN; Wlodarski P; Wasik MA
Oncogene; 2007 Feb; 26(6):813-21. PubMed ID: 16909118
[TBL] [Abstract][Full Text] [Related]
4. RNAi-mediated MEK1 knock-down prevents ERK1/2 activation and abolishes human hepatocarcinoma growth in vitro and in vivo.
Gailhouste L; Ezan F; Bessard A; Frémin C; Rageul J; Langouët S; Baffet G
Int J Cancer; 2010 Mar; 126(6):1367-77. PubMed ID: 19816936
[TBL] [Abstract][Full Text] [Related]
5. ERK MAP kinase signaling in post-mortem brain of suicide subjects: differential regulation of upstream Raf kinases Raf-1 and B-Raf.
Dwivedi Y; Rizavi HS; Conley RR; Pandey GN
Mol Psychiatry; 2006 Jan; 11(1):86-98. PubMed ID: 16172610
[TBL] [Abstract][Full Text] [Related]
6. Loss of active MEK1-ERK1/2 restores epithelial phenotype and morphogenesis in transdifferentiated MDCK cells.
Schramek H; Feifel E; Marschitz I; Golochtchapova N; Gstraunthaler G; Montesano R
Am J Physiol Cell Physiol; 2003 Sep; 285(3):C652-61. PubMed ID: 12900389
[TBL] [Abstract][Full Text] [Related]
7. Major contribution of MEK1 to the activation of ERK1/ERK2 and to the growth of LS174T colon carcinoma cells.
Shama J; Garcia-Medina R; Pouysségur J; Vial E
Biochem Biophys Res Commun; 2008 Aug; 372(4):845-9. PubMed ID: 18533112
[TBL] [Abstract][Full Text] [Related]
8. Properties of MEKs, the kinases that phosphorylate and activate the extracellular signal-regulated kinases.
Zheng CF; Guan KL
J Biol Chem; 1993 Nov; 268(32):23933-9. PubMed ID: 8226933
[TBL] [Abstract][Full Text] [Related]
9. Investigation of the Mek-MAP kinase-Rsk pathway in human breast cancer.
Salh B; Marotta A; Matthewson C; Ahluwalia M; Flint J; Owen D; Pelech S
Anticancer Res; 1999; 19(1B):731-40. PubMed ID: 10216485
[TBL] [Abstract][Full Text] [Related]
10. Activation of RAF/MEK/ERK and PI3K/AKT/mTOR pathways in pituitary adenomas and their effects on downstream effectors.
Dworakowska D; Wlodek E; Leontiou CA; Igreja S; Cakir M; Teng M; Prodromou N; Góth MI; Grozinsky-Glasberg S; Gueorguiev M; Kola B; Korbonits M; Grossman AB
Endocr Relat Cancer; 2009 Dec; 16(4):1329-38. PubMed ID: 19620247
[TBL] [Abstract][Full Text] [Related]
11. A new type of ERK1/2 autophosphorylation causes cardiac hypertrophy.
Lorenz K; Schmitt JP; Schmitteckert EM; Lohse MJ
Nat Med; 2009 Jan; 15(1):75-83. PubMed ID: 19060905
[TBL] [Abstract][Full Text] [Related]
12. Rac-PAK signaling stimulates extracellular signal-regulated kinase (ERK) activation by regulating formation of MEK1-ERK complexes.
Eblen ST; Slack JK; Weber MJ; Catling AD
Mol Cell Biol; 2002 Sep; 22(17):6023-33. PubMed ID: 12167697
[TBL] [Abstract][Full Text] [Related]
13. ERK1/2 MAP kinases: structure, function, and regulation.
Roskoski R
Pharmacol Res; 2012 Aug; 66(2):105-43. PubMed ID: 22569528
[TBL] [Abstract][Full Text] [Related]
14. A Mek1-Mek2 heterodimer determines the strength and duration of the Erk signal.
Catalanotti F; Reyes G; Jesenberger V; Galabova-Kovacs G; de Matos Simoes R; Carugo O; Baccarini M
Nat Struct Mol Biol; 2009 Mar; 16(3):294-303. PubMed ID: 19219045
[TBL] [Abstract][Full Text] [Related]
15. Reduced activation and expression of ERK1/2 MAP kinase in the post-mortem brain of depressed suicide subjects.
Dwivedi Y; Rizavi HS; Roberts RC; Conley RC; Tamminga CA; Pandey GN
J Neurochem; 2001 May; 77(3):916-28. PubMed ID: 11331420
[TBL] [Abstract][Full Text] [Related]
16. Ribonucleotide reductase small subunit p53R2 suppresses MEK-ERK activity by binding to ERK kinase 2.
Piao C; Jin M; Kim HB; Lee SM; Amatya PN; Hyun JW; Chang IY; You HJ
Oncogene; 2009 May; 28(21):2173-84. PubMed ID: 19398949
[TBL] [Abstract][Full Text] [Related]
17. Positive regulation of Raf1-MEK1/2-ERK1/2 signaling by protein serine/threonine phosphatase 2A holoenzymes.
Adams DG; Coffee RL; Zhang H; Pelech S; Strack S; Wadzinski BE
J Biol Chem; 2005 Dec; 280(52):42644-54. PubMed ID: 16239230
[TBL] [Abstract][Full Text] [Related]
18. Flagellin and lipopolysaccharide stimulate the MEK-ERK signaling pathway in chicken heterophils through differential activation of the small GTPases, Ras and Rap1.
Kogut MH; Genovese KJ; He H
Mol Immunol; 2007 Mar; 44(7):1729-36. PubMed ID: 17045653
[TBL] [Abstract][Full Text] [Related]
19. The MEK1 proline-rich insert is required for efficient activation of the mitogen-activated protein kinases ERK1 and ERK2 in mammalian cells.
Dang A; Frost JA; Cobb MH
J Biol Chem; 1998 Jul; 273(31):19909-13. PubMed ID: 9677429
[TBL] [Abstract][Full Text] [Related]
20. Targeting ERK1/2 protein-serine/threonine kinases in human cancers.
Roskoski R
Pharmacol Res; 2019 Apr; 142():151-168. PubMed ID: 30794926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
